Education Litmus

Daily Current Affairs – February 10, 2026

Daily Current Affairs for CAT, XAT & MBA GDPI – February 10, 2026


Download PDF

Indian Economy & Policy


Stock Market LIVE: GIFT Nifty hints at positive start amid strong cues; Asian markets extend gains

Sensex Today | Stock Market LIVE Updates: GIFT Nifty was trading at 25,985 levels, up by 95 points, indicating a positive start for Indian markets amid strong global cues

Interview Angle: Macro impact, policy direction, long-term growth.

Bata India Q3 net profit up 12.6% at ₹66.1 cr, revenue rises 2.8%

It had posted a net profit of ₹58.7 crore in the previous October-December a year ago, according to a regulatory filing from Bata India

Interview Angle: Macro impact, policy direction, long-term growth.

Indian Politics & Governance


Three-language panel submits report to Maharashtra government

Recommendations by the eight-member committee is not yet made public

Interview Angle: Governance implications and institutional impact.

Geopolitics (India Focus)


King Charles ‘ready to support’ U.K. police in ex-prince Andrew misconduct probe related to Epstein files

According to the BBC, emails released in the U.S. indicate Andrew forwarded reports to Epstein, including one from November 2010 sent by his then Indian-origin special assistant Amit Patel, related to official trade visits

Interview Angle: India’s strategic and economic interests.

Indian Stock Market & IPOs


Stock Market LIVE: GIFT Nifty hints at positive start amid strong cues; Asian markets extend gains

Sensex Today | Stock Market LIVE Updates: GIFT Nifty was trading at 25,985 levels, up by 95 points, indicating a positive start for Indian markets amid strong global cues

Interview Angle: Valuation, regulation, investor sentiment.

Bata India Q3 net profit up 12.6% at ₹66.1 cr, revenue rises 2.8%

It had posted a net profit of ₹58.7 crore in the previous October-December a year ago, according to a regulatory filing from Bata India

Interview Angle: Valuation, regulation, investor sentiment.

Marketing, Brands & Consumer Trends


Made in India, but what’s next? Pharma stalwarts debate the future

The occasion was the launch of Made in India, a biography of Lupin's late founder Desh Bandhu Gupta, chronicling his life and, through it, the rise of the Indian pharmaceutical industry itself.

Interview Angle: Consumer behaviour and brand strategy.

HPV vaccines gain traction in India, though cost keeps reach limited

HPV, or human papillomavirus, is linked to several types of cancer, including cervical, anal, and throat cancers. India’s HPV vaccine market was worth ₹91 crore as of January 2026, on a moving annual total basis, according to pharma intelligence platform Pharmarack.

Interview Angle: Consumer behaviour and brand strategy.

Sports (Business & Governance)


BCCI sticks to its policy, bars players from staying with families

Interview Angle: Governance, monetisation, institutional control.
Scroll to Top